COVID-19
Canadian cannabis 2.0 sales are on the rise and other weekly insights from the data firm
Hi, what are you looking for?
Mugglehead Investment Magazine
News
News
Medical and therapeutic benefits are clear even if scalability isn't
COVID-19
The operator of the world's largest weed store reported US$16.6 million in Q1 revenue, but now it can only offer delivery during COVID-19 crisis
Cannabis
The latest in a series of aggressive cutbacks spearheaded by new CEO David Klein
The weed wire
COVID-19 has cooled the overall demand for extraction services, but executives hold out hope for the rest of 2020
Cannabis
The company said lower general sales volumes were offset by higher medical and international sales
The weed wire
Company board approves 1-for-12 share consolidation plan in attempt to remain listed on NYSE
The weed wire
The psychedelic medicine company has surged since going public last month and is quickly expanding its research footprint
The weed wire
The non-psychoactive formulation completed its preclinical trial Monday
COVID-19
The company said it's upped wages for existing employees and started a lunch program to support local restaurants
